Manatt Health Director Alex Morin was quoted in HealthPayerIntelligence on a recent report conducted for the Leukemia and Lymphoma Society (LLS), which investigated patient navigation and access to care in Affordable Care Act marketplace plans. The publication noted that researchers studied network adequacy, the impact of narrow networks on blood cancer treatments, patient experience, the appeals and exceptions processes and consumer protections. “Our bottom line is: a more thoughtful approach about navigating the system – so that patients can get to the right treatment that gets them cured faster – actually may lead to a total cost of care decrease, even if a particular treatment might be higher in cost,” Morin said. Additionally, Morin emphasized that attaining fast results is key for patients who are working against the clock to secure treatment.